Skip to content

Effect of Mask Use on Hemodynamic Responses During Exertion

Effect of Mask Use on Hemodynamic Responses During Exertion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05401331
Enrollment
52
Registered
2022-06-02
Start date
2022-04-01
Completion date
2022-06-10
Last updated
2022-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, COVID-19, Exercise Test, Heart Rate, Mask

Keywords

Dyspnea, Mask, Oxygen Saturation, Blood Pressure, Heart Rate, Exercise Test, COVİD-19

Brief summary

The use of masks is a necessity due to the current pandemic conditions. The aim of the study is to examine the effects of the use of masks during effort on dyspnea and fatigue with hemodynamic parameters.

Detailed description

The use of masks is a necessity due to the current pandemic conditions.There are studies on many parameters such as the effect of mask use on saturation (sp02), heart rate (HR) and blood pressure (BP). To determine whether there is a change in the performance of individuals in the masked and unmasked exercise test during exertion due to the scarcity of masked and unmasked maximal exercise tests and the insufficient measurement of the degree of fatigue felt, and to determine whether there is a change in the performance of individuals with and without mask, and to determine the hemodynamic responses in the body together with dyspnea and felt fatigue. This study will be conducted in order to examine the effect on

Interventions

DEVICETreadmilll

Hemodynamic changes before and after treadmill use

OTHERmask

mask

Sponsors

Saglik Bilimleri Universitesi
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 25 Years
Healthy volunteers
Yes

Inclusion criteria

* Volunteering to work, * To be healthy, * 18-25 age range.

Exclusion criteria

* Unstabil angina pectoris, * Atrial arrhythmia, * Uncontrollable asthma, * Pa02 \< 50 mmHg, * PaCO2\> 70mmHg, * Individuals with valve disease * Tachycardia, bradycardia, * Individuals with a resting systolic blood pressure of 200 mmHg * Smoking, * Presence of effective clinical conditions such as nasal deviation.

Design outcomes

Primary

MeasureTime frameDescription
Measurement of blood pressure changes due to mask useThe period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.Blood pressure reading with sphygmomanometer.
Evaluation of dyspnea scoreThe period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.Dyspnea score was evaluated with the Modified Borg Scale. The Modified Borg Scale is a 0 to 10 numerical score used to measure dyspnea. 0 indicates minimum dyspnea and 10 indicates maximum dyspnea.
Evaluation of the degree of perceived fatigueThe period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.The degree of perceived fatigue was evaluated with the Modified Borg Scale. The Modified Borg Scale was used to assess perceived difficulty. The Modified Borg Scale is a numerical score from 0 to 10. 0 means minimum difficulty and 10 means maximum difficulty.
Measurement of oxygen saturation and heart rate changes due to mask useThe period in which each participant is evaluated by taking the outcome criterion is 30-60 minutes.Oxygen saturation and heart rate were recorded with a pulseoximetry device.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026